Ubs Group Ag Penumbra Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Penumbra Inc stock. As of the latest transaction made, Ubs Group Ag holds 16,234 shares of PEN stock, worth $3.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,234

Previous 19,235 15.6%

Holding current value

$3.9 Million

Previous $3.46 Million 8.96%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.64 - $210.12 $491,083 - $630,570	-3,001 Reduced 15.6%	16,234 $3.15 Million
Q2 2024 Aug 13, 2024	BUY	$172.27 - $223.95 $793,303 - $1.03 Million	4,605 Added 31.48%	19,235 $3.46 Million
Q1 2024 May 13, 2024	BUY	$220.09 - $273.15 $1.19 Million - $1.48 Million	5,414 Added 58.75%	14,630 $3.27 Million
Q4 2023 Feb 09, 2024	SELL	$181.44 - $260.22 $342,377 - $491,035	-1,887 Reduced 17.0%	9,216 $2.32 Million
Q3 2023 Nov 09, 2023	BUY	$240.69 - $338.77 $745,416 - $1.05 Million	3,097 Added 38.68%	11,103 $2.69 Million
Q2 2023 Aug 11, 2023	SELL	$271.54 - $344.06 $191,978 - $243,250	-707 Reduced 8.11%	8,006 $2.75 Million
Q1 2023 May 12, 2023	SELL	$220.43 - $278.69 $1.11 Million - $1.4 Million	-5,015 Reduced 36.53%	8,713 $2.43 Million
Q4 2022 Feb 08, 2023	SELL	$151.88 - $228.5 $563,474 - $847,735	-3,710 Reduced 21.28%	13,728 $3.05 Million
Q3 2022 Nov 10, 2022	BUY	$120.36 - $205.88 $374,801 - $641,110	3,114 Added 21.74%	17,438 $3.31 Million
Q2 2022 Aug 10, 2022	BUY	$116.09 - $227.33 $1.55 Million - $3.04 Million	13,351 Added 1372.15%	14,324 $1.78 Million
Q1 2022 May 16, 2022	SELL	$187.51 - $283.98 $781,166 - $1.18 Million	-4,166 Reduced 81.07%	973 $216,000
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $966,604 - $1.17 Million	4,060 Added 376.27%	5,139 $1.48 Million
Q3 2021 Nov 15, 2021	SELL	$250.72 - $291.24 $2.62 Million - $3.04 Million	-10,449 Reduced 90.64%	1,079 $288,000
Q2 2021 Aug 13, 2021	BUY	$235.0 - $310.7 $1.25 Million - $1.66 Million	5,338 Added 86.24%	11,528 $3.16 Million
Q1 2021 May 12, 2021	BUY	$175.6 - $291.43 $661,485 - $1.1 Million	3,767 Added 155.47%	6,190 $1.68 Million
Q4 2020 Feb 11, 2021	SELL	$174.98 - $272.83 $1.89 Million - $2.95 Million	-10,797 Reduced 81.67%	2,423 $424,000
Q3 2020 Nov 12, 2020	BUY	$185.27 - $238.73 $1.94 Million - $2.5 Million	10,466 Added 380.03%	13,220 $2.57 Million
Q2 2020 Jul 31, 2020	BUY	$153.32 - $191.72 $210,815 - $263,615	1,375 Added 99.71%	2,754 $492,000
Q1 2020 May 01, 2020	SELL	$124.34 - $193.76 $2.28 Million - $3.55 Million	-18,327 Reduced 93.0%	1,379 $223,000
Q4 2019 Feb 14, 2020	BUY	$134.81 - $177.8 $2.39 Million - $3.15 Million	17,728 Added 896.26%	19,706 $3.24 Million
Q3 2019 Nov 14, 2019	SELL	$131.82 - $183.4 $82,651 - $114,991	-627 Reduced 24.07%	1,978 $266,000
Q2 2019 Aug 14, 2019	BUY	$124.65 - $167.39 $70,427 - $94,575	565 Added 27.7%	2,605 $417,000
Q1 2019 May 14, 2019	SELL	$115.84 - $160.31 $68,229 - $94,422	-589 Reduced 22.4%	2,040 $300,000
Q4 2018 Feb 14, 2019	BUY	$113.42 - $156.48 $36,294 - $50,073	320 Added 13.86%	2,629 $321,000
Q3 2018 Nov 14, 2018	SELL	$121.55 - $156.8 $590,611 - $761,891	-4,859 Reduced 67.79%	2,309 $346,000
Q2 2018 Aug 14, 2018	BUY	$112.2 - $165.95 $599,260 - $886,338	5,341 Added 292.34%	7,168 $990,000
Q1 2018 May 15, 2018	SELL	$84.6 - $126.1 $346,775 - $516,883	-4,099 Reduced 69.17%	1,827 $211,000
Q4 2017 Feb 14, 2018	SELL	$91.55 - $115.85 $238,853 - $302,252	-2,609 Reduced 30.57%	5,926 $558,000
Q3 2017 Nov 14, 2017	BUY	$79.65 - $90.3 $73,437 - $83,256	922 Added 12.11%	8,535 $771,000
Q2 2017 Aug 14, 2017	SELL	N/A	-3,877 Reduced 33.74%	7,613 $668,000
Q1 2017 Nov 14, 2017	BUY	N/A	11,490	11,490 $959,000

Others Institutions Holding PEN

# of Institutions

373

Shares Held

29.1M

Call Options Held

305K

Put Options Held

192K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account